NYSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/24/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization260.47 mln
Float48.86 mln
Earnings Date11/11/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-3.55
Highly reliable
1-Year Forecast
11.00
Transformational upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
1.70
High leverage
Pre-Tax Margin
19%
Healthy margin
Business Description
Emergent BioSolutions is a Maryland-based company founded in 1998 that develops and sells medical treatments and vaccines designed to protect people from serious public health threats, including biological agents, infectious diseases, and opioid overdoses. Its product portfolio spans treatments for conditions such as anthrax, botulism, smallpox, and Ebola, and also includes widely used opioid overdose reversal sprays. Beyond its own products, the company supports other drugmakers by providing manufacturing, development, and packaging services.
